今天3分钟我们来聊聊杀癌细胞没事，重置免疫系统却死了3个人

诺华因3名自免病受试者死亡紧急暂停8项CAR-T临床，百时美施贵宝同步暂停相关试验。本期拆解事件背后的风险逻辑，揭秘自免CAR-T赛道的安全新命题。参考文献：Marissa Russo, FierceBiotech, 2026-08-31. "UPDATED: Novartis halts autoimmune CAR-T trials after 3 deaths, as BMS also pauses studies" — 链接Tristan Manalac, BioSpace, 2026-09-01. "Novartis pauses CAR T studies due to 3 deaths; BMS follows suit after safety events" — 链接王聪, 生物世界/网易, 2026-09-02. "3名患者死亡，诺华暂停8项CAR-T自身免疫疾病临床试验" — 链接一一, RNAScript/虎嗅, 2026-09-02. "3例死亡，诺华暂停8项CAR-T自免临床：自身免疫需要怎样的CAR-T?" — 链接前往小宇宙评论区与主播互动